2024年

  • Matsumoto K, Ishihara K, Matsuda K, Tokunaga K, Yamashiro S, Soejima H, Nakashima N, Kamouchi M.

    Machine Learning-Based Prediction for In-Hospital Mortality After Acute Intracerebral Hemorrhage Using Real-World Clinical and Image Data.

    J Am Heart Assoc 13(24): e036447 pubmed

  • Mezuki S, Matsuo R, Irie F, Shono Y, Kuwashiro T, Sugimori H, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.

    Body temperature in the acute phase and clinical outcomes after acute ischemic stroke.

    PLoS One 19(1): e0296639 pubmed

  • Oshiro A, Ohkuma T, Iwase M, Yoshinari Y, Kitazono T.

    Reproductive factors predict risks of cardiovascular disease and premature death in postmenopausal women with type 2 diabetes: the Fukuoka Diabetes Registry.

    Diabetes Res Clin Pract 218: 111907 pubmed

  • Ohkuma T, Iwase M, Kitazono T.

    Sleep duration and its association with constipation in patients with diabetes: the Fukuoka Diabetes Registry.

    PLoS One 19(5): e0302430 pubmed

  • Ueki K, Tsuchimoto A, Matsukuma Y, Ataka E, Okamoto H, Tanaka S, Masutani K, Kitazono T, Nakano T.

    Combined evaluation of glomerular phospholipase A2 receptor and immunoglobulin G subclass in membranous nephropathy.

    Clin Kidney J 17(6): sfae104 pubmed

  • Arase H, Yamada S, Taniguchi M, Ooboshi H, Tsuruya K, Kitazono T, Nakano T.

    Disturbance in the potential cardiovascular-bone-skeletal muscle axis and morbidity and mortality in patients undergoing haemodialysis: the Q-Cohort Study.

    Clin Kidney J 17(6): sfae154 pubmed

  • Yasumura D, Katsukawa H, Matsuo R, Kawano R, Taito S, Liu K, Hodgson C.

    Feasibility and Inter-rater Reliability of the Japanese Version of the Intensive Care Unit Mobility Scale.

    Cureus 16(4): e59135 pubmed

  • Tsuruya K, Yoshida H, Yamada S, Haruyama N, Tanaka S, Tsuchimoto A, Eriguchi M, Fujisaki K, Torisu K, Nakano T, Masutani K, Kitazono T.

    More rapid progression of brain atrophy in patients on peritoneal dialysis compared with hemodialysis: The VCOHP Study.

    Hypertens Res 47(4): 887-897 pubmed

  • Kohara C, Yamada S, Tanaka S, Hiyamuta H, Kitamura H, Arase H, Shimamoto S, Taniguchi M, Tsuruya K, Kitazono T, Nakano T.

    Blood Hemoglobin Concentrations and the Incidence of Lower Extremity Peripheral Arterial Disease in Patients Undergoing Hemodialysis: 10-Year Outcomes of the Q-Cohort Study.

    J Am Heart Assoc 13(15): e033853 pubmed

  • Hiyamuta H, Yamada S, Nakano T, Taniguchi M, Masutani K, Tsuruya K, Kitazono T.

    Impact of Electrocardiographic Parameters on Sudden Death in Patients Receiving Maintenance Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study.

    J Atheroscler Thromb 31(3): 214-231 pubmed

  • Okamura K, Tanaka S, Kitamura H, Hiyamuta H, Tsuruya K, Nakano T, Kitazono T.

    Relationships of Weight Change from 20 Years of Age with the Risks of All-cause and Cardiovascular Mortality in Patients with Chronic Kidney Disease.

    J Atheroscler Thromb 31(7): 1072-1086 pubmed

  • Matsukuma Y, Tsuchimoto A, Masutani K, Ueki K, Tanaka S, Haruyama N, Okabe Y, Nakamura M, Kitazono T, Nakano T.

    Association between hemoglobin A1c and renal arteriolar sclerosis in the subjects without apparent kidney dysfunction.

    J Atheroscler Thromb 31(8): 1215-1224 pubmed

  • Nakano T, Kitamura H, Hata J, Maki K, Oda Y, Kitazono T, Ninomiya T.

    Association between vascular calcification and intraplaque hemorrhage in coronary atherosclerosis from autopsy: the Hisayama Study.

    J Atheroscler Thromb 31(8): 1225-1237 pubmed

  • Tanaka S, Kitamura H, Tsuruya K, Kitazono T, Nakano T^t FKR Study Collaboration Group.

    Impact of Age on Prescribing Patterns of Cardiovascular Medications in Older Japanese Patients with Non-Dialysis-Dependent Chronic Kidney Disease: A Cross-Sectional Study.

    J Atheroscler Thromb 31(10): 1427-1442 pubmed

  • Seki M, Nakano T, Tanaka S, Kitamura H, Hiyamuta H, Ninomiya T, Tsuruya K, Kitazono T.

    Associations between serum triglyceride level and kidney outcome in patients with chronic kidney disease: the Fukuoka Kidney disease Registry Study.

    J Atheroscler Thromb 31(11): 1556-1570 pubmed

  • Haruyama N, Nakayama M, Yamada S, Tanaka S, Hiyamuta H, Taniguchi M, Tokumoto M, Tsuruya K, Kitazono T, Nakano T.

    History of fragility fracture is associated with cardiovascular mortality in hemodialysis patients: the Q-Cohort study.

    J Bone Miner Metab 42(2): 253-263 pubmed

  • Shimamoto S, Nakahara T, Yamada S, Nagasu H, Kishi S, Nakashima N, Tsuruya K, Okada H, Tamura K, Narita I, Maruyama S, Yano Y, Yokoo T, Wada T, Wada J, Kanda E, Kataoka H, Nangaku M, Kashihara N, Nakano T.

    Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex).

    Sci Rep 14(1): 27481 pubmed

  • Yamada S, Arase H, Taniguchi M, Kitazono T, Nakano T.

    A simple score for malnutrition-inflammation complex syndrome (MICS) is associated with the risk of mortality in Japanese patients undergoing maintenance hemodialysis.

    Ther Apher Dial 28(2): 206-217 pubmed

  • Maezono A, Sakata S, Hata J, Oishi E, Furuta Y, Shibata M, Ide T, Kitazono T, Tsutsui H, Ninomiya T.

    Day-to-day home blood pressure variability and risk of atrial fibrillation in a general Japanese population: the Hisayama Study

    Eur J Prev Cardiol 31(9): 1115-1122 pubmed

  • Kimura Y, Hata J, Shibata M, Honda T, Sakata S, Furuta Y, Oishi E, Kitazono T, Ninomiya T.

    Skin carotenoid scores and metabolic syndrome in a general Japanese population: the Hisayama study

    Int J Obes (Lond) 48(10): 1465-1471 pubmed

  • Setoyama Y, Honda T, Tajimi T, Sakata S, Oishi E, Furuta Y, Shibata M, Hata J, Kitazono T, Nakashima Y, Ninomiya T.

    Association between dynapenic obesity and risk of cardiovascular disease: The Hisayama study

    J Cachexia Sarcopenia Muscle 15(6): 2338-2348 pubmed

  • Tsuda S, Honda T, Higashioka M, Hata J, Nakano T, Kitazono T, Ninomiya T.

    Longitudinal association of sedentary time with diabetes mellitus and markers of glucose metabolism in middle-aged and older adults: The Hisayama Study

    J Diabetes Investig 15(2): 245-246 pubmed

  • Kawatoko K, Washio Y, Ohara T, Fukuyama S, Honda T, Hata J, Nakazawa T, Kan-O K, Inoue H, Matsumoto K, Nakao T, Kitazono T, Okamoto I, Ninomiya T.

    Risks of Dementia in a General Japanese Older Population With Preserved Ratio Impaired Spirometry: The Hisayama Study

    J Epidemiol 34(7): 331-339 pubmed

  • Hirabayashi N, Hata J, Furuta Y, Nakazawa T, Ohara T, Shibata M, Yamashita F, Kitazono T, Sudo N, Ninomiya T.

    Association Between Serum NT-proBNP and Gray Matter Atrophy Patterns in an Older Japanese Population: The Hisayama Study

    J Gerontol A Biol Sci Med Sci 79(5): glae075 pubmed

  • Irie F, Matsuo R, Mezuki S, Wakisaka Y, Kamouchi M, Kitazono T, Ago T; Fukuoka Stroke Registry Investigators.

    Effect of smoking status on clinical outcomes after reperfusion therapy for acute ischemic stroke.

    Sci Rep 14(1): 9290 pubmed

  • Nakamura S, Ueda E, Ohara T, Hata J, Honda T, Fujiwara K, Furuta Y, Shibata M, Hashimoto S, Nakazawa T, Nakao T, Kitazono T, Sonoda KH, Ninomiya T.

    Association between retinopathy and risk of dementia in a general Japanese population: the Hisayama Study

    Sci Rep 14(1): 12017 pubmed

  • Kido-Nakahara M, Onozuka D, Izuhara K, Saeki H, Nunomura S, Takenaka M, Matsumoto M, Kataoka Y, Fujimoto R, Kaneko S, Morita E, Tanaka A, Saito R, Okano T, Miyagaki T, Aoki N, Nakajima K, Ichiyama S, Tonomura K, Nakagawa Y, Tamagawa-Mineoka R, Masuda K, Takeichi T, Akiyama M, Ishiuji Y, Katsuta M, Kinoshita Y, Tateishi C, Yamamoto A, Morita A, Matsuda-Hirose H, Hatano Y, Kawasaki H, Fukushima-Nomura A, Ohtsuki M, Kamiya K, Kabata Y, Abe R, Mitsui H, Kawamura T, Tsuji G, Furue M, Katoh N, Nakahara T.

    Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis.

    Allergol Int 73(2): 332-334 pubmed

  • Izuhara K, Nunomura S, Nakahara T, Onozuka D.

    The search for blood biomarkers useful in treating atopic dermatitis patients.

    Expert Rev Clin Pharmacol 17(12): 1163-1172 pubmed

  • Kido-Nakahara M, Onozuka D, Izuhara K, Saeki H, Nunomura S, Takenaka M, Matsumoto M, Kataoka Y, Fujimoto R, Kaneko S, Morita E, Tanaka A, Hide M, Okano T, Miyagaki T, Aoki N, Nakajima K, Ichiyama S, Tonomura K, Nakagawa Y, Tamagawa-Mineoka R, Masuda K, Takeichi T, Akiyama M, Ishiuji Y, Katsuta M, Kinoshita Y, Tateishi C, Yamamoto A, Morita A, Matsuda-Hirose H, Hatano Y, Kawasaki H, Tanese K, Ohtsuki M, Kamiya K, Kabata Y, Abe R, Mitsui H, Kawamura T, Tsuji G, Furue M, Katoh N, Nakahara T.

    Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis.

    J Allergy Clin Immunol Glob 3(4): 100317 pubmed

  • Takeuchi S, Murakami Y, Matsunaka H, Nakahara T, Furue M.

    Physiological effects of appropriate washing on xerotic skin.

    J Cosmet Dermatol 23(3): 876-885 pubmed

  • Ohata C, Anezaki H, Yanase T, Katayama E, Kaneko S, Saito K, Yamane M, Nakamaru S, Tsuruta N, Okazaki F, Ito K, Kikuchi S, Koike Y, Miyagi T, Sugita K, Nakahara T, Takezaki D, Saruwatari H, Yoshida Y, Yonekura K, Higashi Y, Sawada Y, Chinuki Y, Yamaguchi K, Imafuku S.

    Real-world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study.

    J Dermatol 51(12): 1634-1640 pubmed

  • Beck LA, Bissonnette R, Deleuran M, Nakahara T, Galus R, Coleman A, Gherardi G, Xiao J, Dingman R, Xu C, Avetisova E, Dubost-Brama A, Shabbir A.

    Dupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension Study.

    JAMA Dermatol 160(8): 805-812 pubmed

  • Irie F, Matsumoto K, Matsuo R, Nohara Y, Wakisaka Y, Ago T, Nakashima N, Kitazono T, Kamouchi M.

    Predictive Performance of Machine Learning-Based Models for Poststroke Clinical Outcomes in Comparison With Conventional Prognostic Scores: Multicenter, Hospital-Based Observational Study.

    JMIR AI 3: e46840 pubmed

  • Furuhashi H, Honda T, Furuta Y, Tomooka S, Tajimi T, Kimura Y, Yoshida D, Ninomiya T.

    Association between masticatory function, frailty, and functional disability: an observational study

    BMC Geriatr 24(1): 538 pubmed

  • Fujiwara K, Ueda E, Hata J, Nakano S, Hashimoto S, Nakamura S, Murakami Y, Kubota T, Yoshitomi T, Ninomiya T, Sonoda KH.

    Association between corneal hysteresis and glaucoma in a Japanese population: the Hisayama Study

    Br J Ophthalmol 108(9): 1204-1209 pubmed

  • Laguzzi F, Åkesson A, Marklund M, Qian F, Gigante B, Bartz TM, Bassett JK, Birukov A, Campos H, Hirakawa Y, Imamura F, Jäger S, Lankinen M, Murphy RA, Senn M, Tanaka T, Tintle N, Virtanen JK, Yamagishi K, Allison M, Brouwer IA, De Faire U, Eiriksdottir G, Ferrucci L, Forouhi NG, Geleijnse JM, Hodge AM, Kimura H, Laakso M, Risérus U, van Westing AC, Bandinelli S, Baylin A, Giles GG, Gudnason V, Iso H, Lemaitre RN, Ninomiya T, Post WS, Psaty BM, Salonen JT, Schulze MB, Tsai MY, Uusitupa M, Wareham NJ, Oh SW, Wood AC, Harris WS, Siscovick D, Mozaffarian D, Leander K; Fatty Acids and Outcomes Research Consortium (FORCE).

    Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies

    Circulation 149(4): 305-316 pubmed

  • Nakamura Y, Shibata M, Morisaki Y, Hirabayashi N, Higashioka M, Hata J, Hosoi M, Sudo N, Yamaura K, Ninomiya T.

    Autonomic nervous system function assessed by heart rate variability and the presence of symptoms affecting activities of daily living in community-dwelling residents with chronic pain: The Hisayama Study

    Eur J Pain 28(5): 831-844 pubmed

  • Yagita K, Honda H, Ohara T, Koyama S, Noguchi H, Oda Y, Yamasaki R, Isobe N, Ninomiya T.

    Association between hypothalamic Alzheimer's disease pathology and body mass index: The Hisayama study

    Neuropathology 44(5): 388-400 pubmed

  • Shima A, Noguchi-Shinohara M, Shibata S, Usui Y, Tatewaki Y, Thyreau B, Hata J, Ohara T, Honda T, Taki Y, Nakaji S, Maeda T, Mimura M, Nakashima K, Iga JI, Takebayashi M, Nishijo H, Ninomiya T, Ono K; Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD) study group.

    Glucose metabolism and smaller hippocampal volume in elderly people with normal cognitive function

    NPJ Aging 10(1): 39 pubmed

  • Furuta Y, Akiyama M, Hirabayashi N, Honda T, Shibata M, Ohara T, Hata J, Terao C, Momozawa Y, Tatewaki Y, Taki Y, Nakaji S, Maeda T, Ono K, Mimura M, Nakashima K, Iga JI, Takebayashi M, Ninomiya T; Japan Prospective Studies for Aging and Dementia (JPSC-AD) Study Group.

    Common protein-altering variant in GFAP is associated with white matter lesions in the older Japanese population

    NPJ Genom Med 9(1): 59 pubmed

  • Akiyama M, Tamiya G, Fujiwara K, Shiga Y, Yokoyama Y, Hashimoto K, Sato M, Sato K, Narita A, Hashimoto S, Ueda E, Furuta Y, Hata J, Miyake M, Ikeda HO, Suda K, Numa S, Mori Y, Morino K, Murakami Y, Shimokawa S, Nakamura S, Yawata N, Fujisawa K, Yamana S, Mori K, Ikeda Y, Miyata K, Mori K, Ogino K, Koyanagi Y, Kamatani Y; Biobank Japan Project; Ninomiya T, Sonoda KH, Nakazawa T; Japan Glaucoma Society Omics Group; Genomic Research Committee of the Japanese Ophthalmological Society.

    Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese Individuals

    Ophthalmology 131(11): 1271-1280 pubmed

  • Wakisaka K, Matsuo R, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.

    Association between abdominal adiposity and clinical outcomes in patients with acute ischemic stroke.

    PLoS One 19(1): e0296833 pubmed

  • Koyama S, Yagita K, Hamasaki H, Noguchi H, Shijo M, Matsuzono K, Takase KI, Kai K, Aishima SI, Itoh K, Ninomiya T, Sasagasako N, Honda H.

    Novel method for classification of prion diseases by detecting PrP(res) signal patterns from formalin-fixed paraffin-embedded samples

    Prion 18(1): 40-53 pubmed

  • Ohara T, Tatebe H, Hata J, Honda T, Shibata M, Matsuura S, Mikami T, Maeda T, Ono K, Mimura M, Nakashima K, Iga JI, Takebayashi M, Tokuda T, Ninomiya T; JPSC‐AD (Japan Prospective Studies Collaboration for Aging and Dementia) study group.

    Plasma biomarkers for predicting the development of dementia in a community-dwelling older Japanese population

    Psychiatry Clin Neurosci 78(6): 362-371 pubmed

  • Tachibana A, Iga JI, Ozaki T, Yoshida T, Yoshino Y, Shimizu H, Mori T, Furuta Y, Shibata M, Ohara T, Hata J, Taki Y, Mikami T, Maeda T, Ono K, Mimura M, Nakashima K, Takebayashi M, Ninomiya T, Ueno SI; JPSC-AD study group.

    Serum high-sensitivity C-reactive protein and dementia in a community-dwelling Japanese older population (JPSC-AD)

    Sci Rep 14(1): 7374 pubmed

  • Tachibana A, Iga JI, Ozaki T, Yoshino Y, Yamazaki K, Ochi S, Kawabe K, Horiuchi F, Yoshida T, Shimizu H, Mori T, Tatewaki Y, Taki Y, Ninomiya T, Ueno SI.

    Behavioral and psychological symptoms and brain volumes in community-dwelling older persons from the Nakayama Study

    Sci Rep 14(1): 26097 pubmed

  • Moriyama S, Hieda M, Kisanuki M, Kawano S, Yokoyama T, Fukata M, Kusaba H, Maruyama T, Baba E, Akashi K, Fukuda H.

    Both New-Onset and Pre-Existing Hypertension Indicate Favorable Clinical Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor Therapy.

    Circ J 88(2): 217-225 pubmed

  • Toriu N, Yamamoto S, Matsubara T, Kataoka Y, Sakai K, Funakoshi T, Horimatsu T, Tsukamoto T, Murakami N, Jhaveri KD, Fukuma S, Terada T, Muto M, Fukuhara S, Yanagita M.

    Cancer diagnosis and prognosis after initiation of hemodialysis: multicenter Japan CANcer and DialYsis (J-CANDY) study. Onconephrology Consortium in Japan.

    Clin Kidney J 18(2): sfae430 pubmed

  • Shimoi T, Sunami K, Tahara M, Nishiwaki S, Tanaka S, Baba E, Kanai M, Kinoshita I, Shirota H, Hayashi H, Nishida N, Kubo T, Mamesaya N, Ando Y, Okita N, Shibata T, Nakamura K, Yamamoto N.

    Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial.

    EClinicalMedicine 69: 102447 pubmed

  • Shitara K, Fleitas T, Kawakami H, Curigliano G, Narita Y, Wang F, Wardhani SO, Basade M, Rha SY, Wan Zamaniah WI, Sacdalan DL, Ng M, Yeh KH, Sunpaweravong P, Sirachainan E, Chen MH, Yong WP, Peneyra JL, Ibtisam MN, Lee KW, Krishna V, Pribadi RR, Li J, Lui A, Yoshino T, Baba E, Nakayama I, Pentheroudakis G, Shoji H, Cervantes A, Ishioka C, Smyth E.

    Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer.

    ESMO Open 9(2): 102226 pubmed

  • Ichihara E, Ochi N, Makimoto G, Kudo K, Harada D, Ozaki Y, Nishio H, Tsuchihashi K, Miura Y, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Kubo T.

    Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.

    Int J Clin Oncol 29(4): 355-362 pubmed

  • Maeda T, Najima Y, Kamiyama Y, Nakao S, Ozaki Y, Nishio H, Tsuchihashi K, Ichihara E, Miumra Y, Endo M, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Uchino K, Kimura T, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Yano S.

    Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.

    Int J Clin Oncol 29(5): 535-544 pubmed

  • Uchino K, Tamura S, Kimura S, Shigeta K, Kimura T, Ozaki Y, Nishio H, Tsuchihashi K, Ichihara E, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Miura Y.

    Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.

    Int J Clin Oncol 29(5): 545-550 pubmed

  • Ozaki Y, Yokoe T, Yoshinami T, Nozawa K, Nishio H, Tsuchihashi K, Ichihara E, Miura Y, Endo M, Yano S, Maruyama D, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T.

    Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.

    Int J Clin Oncol 29(5): 551-558 pubmed

  • Kimura S, Shigeta K, Tamura S, Uchino K, Kimura T, Ozaki Y, Nishio H, Tsuchihashi K, Ichihara E, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Miura Y.

    Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.

    Int J Clin Oncol 29(5): 559-563 pubmed

  • Yoshinami T, Nozawa K, Yokoe T, Ozaki Y, Nishio H, Tsuchihashi K, Ichihara E, Miura Y, Endo M, Yano S, Maruyama D, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T.

    Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.

    Int J Clin Oncol 29(6): 681-688 pubmed

  • Ito M, Okumura Y, Nio K, Baba E, Ozaki Y, Nishio H, Ichihara E, Miura Y, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ochi N, Kubo T, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Tsuchihashi K.

    Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.

    Int J Clin Oncol 29(6): 689-699 pubmed

  • Tsuchihashi K, Ito M, Okumura Y, Nio K, Ozaki Y, Nishio H, Ichihara E, Miura Y, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ochi N, Kubo T, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Baba E.

    Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.

    Int J Clin Oncol 29(6): 700-705 pubmed

  • Najima Y, Maeda T, Kamiyama Y, Nakao S, Ozaki Y, Nishio H, Tsuchihashi K, Ichihara E, Miumra Y, Endo M, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Uchino K, Kimura T, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Yano S.

    Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.

    Int J Clin Oncol 29(7): 899-910 pubmed

  • Hirose T, Ito M, Tsuchihashi K, Ozaki Y, Nishio H, Ichihara E, Miura Y, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Baba E, Ochi N, Kubo T, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Endo M.

    Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.

    Int J Clin Oncol 29(8): 1067-1073 pubmed

  • Nozawa K, Ozaki Y, Yoshinami T, Yokoe T, Nishio H, Tsuchihashi K, Ichihara E, Miura Y, Endo M, Yano S, Maruyama D, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T.

    Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022.

    Int J Clin Oncol 29(8): 1074-1080 pubmed

  • Hirose T, Ito M, Tsuchihashi K, Ozaki Y, Nishio H, Ichihara E, Miura Y, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Baba E, Ochi N, Kubo T, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Endo M.

    Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.

    Int J Clin Oncol 29(8): 1081-1087 pubmed

  • Yamamoto Y, Yukami H, Yamaguchi T, Ohori H, Nagasu S, Kagawa Y, Sugimoto N, Sonoda H, Yamazaki K, Takashima A, Okuyama H, Hasegawa H, Kondo C, Baba E, Matsumoto T, Kawamoto Y, Kataoka M, Shindo Y, Ishikawa T, Esaki T, Kito Y, Sato T, Funakoshi T, Yamaguchi T, Shimada Y, Moriwaki T.

    Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study.

    Int J Clin Oncol 29(12): 1878-1886 pubmed

  • Yamaguchi K, Ito M, Isobe T, Koreishi S, Taguchi R, Uehara K, Ueno S, Imajima T, Kitazono T, Tsuchihashi K, Ohmura H, Yoshihiro T, Tanoue K, Nishiyori S, Iwama E, Maeda T, Akashi K, Baba E.

    Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer.

    JCO Precis Oncol 8: e2300681 pubmed

  • Tsuchihashi K, Baba E.

    Epithelioid hemangioendothelioma-its history, clinical features, molecular biology and current therapy.

    Jpn J Clin Oncol 54(7): 739-747 pubmed

  • Kato K, Machida R, Ito Y, Daiko H, Ozawa S, Ogata T, Hara H, Kojima T, Abe T, Bamba T, Watanabe M, Kawakubo H, Shibuya Y, Tsubosa Y, Takegawa N, Kajiwara T, Baba H, Ueno M, Takeuchi H, Nakamura K, Kitagawa Y.

    Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial. JCOG1109 investigators.

    Lancet 404(10447): 55-66 pubmed

  • Tanoue K, Ohmura H, Uehara K, Ito M, Yamaguchi K, Tsuchihashi K, Shinohara Y, Lu P, Tamura S, Shimokawa H, Isobe T, Ariyama H, Shibata Y, Tanaka R, Kusaba H, Esaki T, Mitsugi K, Kiyozawa D, Iwasaki T, Yamamoto H, Oda Y, Akashi K, Baba E.

    Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.

    Nat Commun 15(1): 9033 pubmed

  • Ishimaru K, Ikeda M, Miyamoto HD, Furusawa S, Abe K, Watanabe M, Kanamura T, Fujita S, Nishimura R, Toyohara T, Matsushima S, Koumura T, Yamada KI, Imai H, Tsutsui H, Ide T.

    Deferasirox Targeting Ferroptosis Synergistically Ameliorates Myocardial Ischemia Reperfusion Injury in Conjunction With Cyclosporine A.

    J Am Heart Assoc 13(1): e031219 pubmed

  • Yamamoto S, Sanefuji M, Suzuki M, Sonoda Y, Hamada N, Kato W, Ono H, Oba U, Nakashima K, Ochiai M, Kusuhara K, Koga Y, Ohga S.

    Pediatric leukemia and maternal occupational exposure to anticancer drugs: the Japan Environment and Children's Study.

    Blood 143(4): 311-319 pubmed

  • Kinjo Y, Shibata E, Askew DJ, Tanaka R, Suga R, Shimono M, Sakuragi T, Morokuma S, Ogawa M, Sanefuji M, Hamada N, Ochiai M, Ohga S, Tsuji M, Kusuhara K, Yoshino K; Japan Environment and Children's Study Group.

    Association of placental weight at birth with maternal whole blood concentration of heavy metals (cadmium, lead, mercury, selenium, and manganese): The Japan Environment and Children's Study (JECS).

    Environ Int 188: 108725 pubmed

  • Kikuchi K, Michikawa T, Morokuma S, Hamada N, Ikeda S, Shimada Y, Kato K, Ochiai M, Tsuji M, Shimono M, Yoshino K, Suga R, Kawamoto T, Ohga S; Japan Environment and Children’s Study Group.

    Infants' early recovery from sleep disturbance is associated with a lower risk of developmental delay in the Japan Environment and Children's Study.

    Sci Rep 14(1): 17773 pubmed

© 2020- Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University.